Science Researcher Update: Spotlight on Meetings, Conferences, and Events

7th Viral Safety for Biologicals 2014

Posted on Jun 19, 2014 4:01:00 PM

 

Conference - Cologne, Germany

18+ industry case studies on minimising viral contamination risk including new insights from Eli Lilly and Company, Merck Serono, Regeneron Pharmaceuticals and Novartis Pharma AG.Independent analysis from Baxter BioScience on the application and implementation of next-generation detection technologies for rapid virus identification.

Genzyme and Sanofi Pasteur evaluate the implementation of upstream viral clearance barriers to reduce the risk of contamination from raw materials and media.
Roche Diagnostics present the first FDA approved viral clearance design space following QbD principles.
NEW interactive strategic panel discussions on dealing with pressure release during nanofiltration and strategies to handle suspected contaminations.
Critical regulatory advice from the FDA and PEI on the use of next-generation detection technologies, in-house data in viral clearance and viral safety standards expected.

Organization: Informa IIR

Viral Safety for Biologicals

Tue, Jun 24, 2014 - Wed, Jun 25, 2014 (09:00-14:30)

Hotel Pullman Cologne

14 Cologne Helenenstr, Cologne, Germany

If you'd like to ask a question or post a comment about this talk please do so below.

This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.

Tags: 2014, June, Pharmacology, germany, Cologne, biological, Life Sciences, Conference

This meeting information is brought to you by Biotechnology Calendar, Inc

We connect researchers with the tools they need to succeed. 

Get 2020 Schedule

sell more lab supplies